[Hiring] Director, Global Value Evidence Strategy @Otsuka Pharmaceutical Co., Ltd.

Role Description

The Director, Global Value Evidence Strategy role is responsible for leading global value evidence strategy for assigned nephrology/immunology asset(s), providing strategic input into integrated evidence plans and leading evidence generation to support value demonstration, market access, reimbursement, and patient access objectives. This individual also leads the Value Evidence Sub-Committee for relevant product and indications globally. This position reports to the Executive Director, Global Value Evidence.

• Responsibility for leading and coordinating the health technology and value evidence input into clinical development programs.
• Serves on product development committee and supports the ED for tasks related to internal and/or alliance governance committees.
• Lead Value Evidence Sub-Committee.
• Serve as Value Evidence lead in development and maintenance of Integrated Evidence Plan (IEP).
• Develops the global value evidence strategy taking into account payer (including health technology assessment agencies), provider, patient, and policy maker evidence needs.
• Assess the HTA needs for the assigned product and disease area in general and tracking the methodological needs.
• Responsibility for completion of all global deliverables for the assigned product/indication to support HTA and reimbursement submissions, including economic models, real world evidence, evidence synthesis & meta-analysis, global HTA statistical analysis plan, and global value dossier, and AMCP-format dossier.
• Coordinates and provides scientific support for HTA submissions outside the US, with subsidiaries. Leads Company responses to HTA evaluations in the US (e.g., ICER).
• Develops and generates post-approval real world evidence on our company's product in collaboration with external researchers and experts in the field.
• Responsibility for developing a comprehensive publication and communication plan including presentation and publication of key value evidence at scientific conferences and peer reviewed journals.

Qualifications

• Minimum 6 years for PhD/MD/Pharm D or 12 years for Master's degree of relevant pharmaceutical company or payer experience in the area of access, outcomes research, health economics, observational studies, Health Technology Assessment or related area.
• Late stage drug development and launch experience.
• Experience with evidence generation in rare diseases.
• PhD or Master's in health economics, outcomes research, epidemiology, health services research, health policy, pharmaceutical administration or related field OR MD or Pharm D.

Requirements

• Accountability for Results - Stay focused on key strategic objectives, be accountable for high standards of performance, and take an active role in leading change.
• Strategic Thinking & Problem Solving - Make decisions considering the long-term impact to customers, patients, employees, and the business.
• Patient & Customer Centricity - Maintain an ongoing focus on the needs of our customers and/or key stakeholders.
• Impactful Communication - Communicate with logic, clarity, and respect. Influence at all levels to achieve the best results for Otsuka.
• Respectful Collaboration - Seek and value others’ perspectives and strive for diverse partnerships to enhance work toward common goals.
• Empowered Development - Play an active role in professional development as a business imperative.

Benefits

• Comprehensive medical, dental, vision, prescription drug coverage.
• Company provided basic life, accidental death & dismemberment, short-term and long-term disability insurance.
• Tuition reimbursement, student loan assistance.
• A generous 401(k) match.
• Flexible time off, paid holidays, and paid leave programs.
• Other company provided benefits.